MA40369A - Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil - Google Patents
Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œilInfo
- Publication number
- MA40369A MA40369A MA040369A MA40369A MA40369A MA 40369 A MA40369 A MA 40369A MA 040369 A MA040369 A MA 040369A MA 40369 A MA40369 A MA 40369A MA 40369 A MA40369 A MA 40369A
- Authority
- MA
- Morocco
- Prior art keywords
- foods
- drugs
- preparation
- cistanche tubulosa
- ocular cells
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 235000013305 food Nutrition 0.000 title abstract 3
- 241000336316 Cistanche tubulosa Species 0.000 title abstract 2
- 208000022873 Ocular disease Diseases 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne des applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection des cellules de l'œil. Ledit extrait permet aussi d'obtenir un médicament ou produit permettant de prévenir les maladies de l'œil ou retarder la progression des maladies de l'œil.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462020409P | 2014-07-03 | 2014-07-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA40369A true MA40369A (fr) | 2017-06-21 |
Family
ID=55016238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA040369A MA40369A (fr) | 2014-07-03 | 2015-07-03 | Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil |
Country Status (10)
Country | Link |
---|---|
US (2) | US20160000847A1 (fr) |
EP (1) | EP3181143B8 (fr) |
JP (1) | JP6573961B2 (fr) |
KR (1) | KR20170039160A (fr) |
CN (2) | CN112870258A (fr) |
MA (1) | MA40369A (fr) |
MY (1) | MY192535A (fr) |
RU (1) | RU2688939C2 (fr) |
TW (1) | TWI650131B (fr) |
WO (1) | WO2016000663A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6599505B2 (ja) | 2018-04-27 | 2019-10-30 | 株式会社ダイヘン | アークエンド調整装置、溶接システム、アークエンド調整方法及びコンピュータプログラム |
KR20240042585A (ko) * | 2021-05-06 | 2024-04-02 | 신파 티엔리 파머슈티컬 컴퍼니 리미티드 (항저우) | 안구 건조증을 완화하기 위한 약품의 조제에서의 육종용 추출물의 용도 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2348901A (en) * | 1999-11-11 | 2001-06-06 | Dietrich Paper | Use of an extract from plantago lanceolata |
CN1268341C (zh) * | 2003-03-04 | 2006-08-09 | 杏辉天力(杭州)药业有限公司 | 来源于管花肉苁蓉的含有苯乙醇苷的制剂及其制备方法和用途 |
JP4936507B2 (ja) * | 2006-01-18 | 2012-05-23 | 学校法人近畿大学 | カンカニクジュヨウの抽出物より得られる強壮剤又は強精剤、配糖体化合物及びそれらの用途 |
CN100475189C (zh) * | 2006-10-17 | 2009-04-08 | 王海龙 | 一种化妆品组合物及其制备方法和应用 |
JP2008239505A (ja) * | 2007-03-26 | 2008-10-09 | Oriza Yuka Kk | 神経芽細胞増殖促進剤及び神経突起伸展剤 |
JP5264107B2 (ja) * | 2007-06-01 | 2013-08-14 | 小林製薬株式会社 | 抗酸化作用を有する組成物 |
CN101331906A (zh) * | 2007-06-28 | 2008-12-31 | 杏辉天力(杭州)药业有限公司 | 含苁蓉成分和咖啡成分的饮品 |
CN101322750B (zh) * | 2008-06-04 | 2012-01-04 | 张小平 | 管花肉苁蓉提取物的新用途 |
TWI486162B (zh) * | 2010-06-16 | 2015-06-01 | Sinphar Pharmaceutical Co Ltd | 異類葉升麻苷或其醫藥學上可接受之鹽於抑制澱粉樣β肽生成、累積或聚集、以及製備預防或治療澱粉樣β肽相關疾病或狀況的藥物之用途 |
WO2012158591A1 (fr) * | 2011-05-18 | 2012-11-22 | The Research Foundation Of State University Of New York | Produits et méthodes anti-blépharite |
JP5969738B2 (ja) * | 2011-07-25 | 2016-08-17 | 丸善製薬株式会社 | 抗糖化作用剤 |
JP6134331B2 (ja) * | 2011-12-16 | 2017-05-24 | 杏輝天力(杭州)藥業有限公司 | アミロイドベータペプチド関連の疾患または症状の予防または治療のための医薬組成物 |
CN102813753B (zh) * | 2012-05-22 | 2014-02-26 | 孟令刚 | 含有苁蓉或锁阳与菊花、牛磺酸、番茄红素、叶黄素、β-胡萝卜素组合的组合物 |
JP6151003B2 (ja) * | 2012-10-26 | 2017-06-21 | 学校法人近畿大学 | カンカニクジュヨウから得られる抗糖尿病剤、ヒト又は動物用医薬および機能性食品 |
US9339522B2 (en) * | 2013-05-30 | 2016-05-17 | Sinphar Pharmaceutical Co., Ltd. | Method for regulating blood glucose level |
CN103896997B (zh) * | 2014-04-14 | 2016-07-06 | 青海伊纳维康生物科技有限公司 | 一种肉苁蓉中毛蕊花糖苷的分离纯化方法 |
-
2015
- 2015-07-01 TW TW104121352A patent/TWI650131B/zh active
- 2015-07-02 US US14/790,017 patent/US20160000847A1/en not_active Abandoned
- 2015-07-03 CN CN202110209988.2A patent/CN112870258A/zh active Pending
- 2015-07-03 MA MA040369A patent/MA40369A/fr unknown
- 2015-07-03 JP JP2017501159A patent/JP6573961B2/ja active Active
- 2015-07-03 WO PCT/CN2015/083315 patent/WO2016000663A1/fr active Application Filing
- 2015-07-03 CN CN201510397778.5A patent/CN105232640A/zh active Pending
- 2015-07-03 RU RU2017102407A patent/RU2688939C2/ru active
- 2015-07-03 KR KR1020177002601A patent/KR20170039160A/ko active Search and Examination
- 2015-07-03 EP EP15814428.7A patent/EP3181143B8/fr active Active
- 2015-07-03 MY MYPI2017000001A patent/MY192535A/en unknown
-
2017
- 2017-12-26 US US15/854,722 patent/US10967029B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
RU2017102407A3 (fr) | 2018-08-03 |
EP3181143B8 (fr) | 2020-11-18 |
WO2016000663A1 (fr) | 2016-01-07 |
CN105232640A (zh) | 2016-01-13 |
EP3181143A4 (fr) | 2018-05-16 |
TW201601740A (zh) | 2016-01-16 |
EP3181143B1 (fr) | 2020-09-23 |
KR20170039160A (ko) | 2017-04-10 |
US20180117109A1 (en) | 2018-05-03 |
JP2017531614A (ja) | 2017-10-26 |
RU2017102407A (ru) | 2018-08-03 |
MY192535A (en) | 2022-08-26 |
TWI650131B (zh) | 2019-02-11 |
EP3181143A1 (fr) | 2017-06-21 |
US10967029B2 (en) | 2021-04-06 |
JP6573961B2 (ja) | 2019-09-11 |
US20160000847A1 (en) | 2016-01-07 |
CN112870258A (zh) | 2021-06-01 |
RU2688939C2 (ru) | 2019-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3413851A4 (fr) | Kit d'injection oculaire, conditionnement et procédés d'utilisation | |
CA2956871C (fr) | Composes actifs envers des bromodomaines | |
HK1223628A1 (zh) | β- 新的 -酮- β-烷基膽烷酸衍生物在製備奧貝膽酸以及其在醫藥領域的用途 | |
EP3177732A4 (fr) | Compositions et procédés pour le traitement de maladies et états pathologiques ophthalmiques | |
IL285258A (en) | Retinal ganglion cells and their progenitor cells | |
EP3167046A4 (fr) | Production et cryopréservation de cellules fucosylées à usage thérapeutique | |
EP3191022A4 (fr) | Implants ophtalmiques avec profondeur de champ étendue et acuité visuelle à distance renforcée | |
EP3188688A4 (fr) | Méthodes et compositions biocompatibles pour obtenir une libération prolongée de médicament dans l' il | |
EP3124741A4 (fr) | Agent de soutènement auto-suspendu, sa préparation et son utilisation | |
EP3102291A4 (fr) | Progranuline (pgrn) et ses dérivés pour le diagnostic et le traitement de maladies lysosomales | |
EP3154533A4 (fr) | Procédés d'anesthésie de tissu nerveux dans la voie du nerf trijumeau et utilisations médicales de ceux-ci | |
EP3220912A4 (fr) | Combinaisons d'un inhibiteur de tlr et d'un inhibiteur de la tyrosine kinase de bruton | |
AU356247S (en) | Coffee maker | |
EP3397752A4 (fr) | Cellules du noeud sinusal et de purkinje induites issues de cellules souches adultes | |
EP3281539A4 (fr) | Article de lingerie féminine et moyen de fixation | |
EP3721890A4 (fr) | Préparation médicamenteuse ophtalmique et ses utilisations | |
EP3246036A4 (fr) | Medicament pour ameliorer l'etat de grossesse, et son utilisation | |
EP3238758A4 (fr) | Hémodiafiltre et dispositif d'hémodiafiltration | |
EP3167893A4 (fr) | Compositions pharmaceutiques contenant un extrait de spirulina maxima en tant que principe actif pour la prévention et le traitement de maladies rétiniennes | |
HK1243327A1 (zh) | 包含螺旋藻和棕櫚酰基乙醇酰胺和/或其鹽或藥用上可接受衍生物的組合及其製劑,用於預防和/或治療過度活化的組織病症 | |
MA40369A (fr) | Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil | |
EP3197466A4 (fr) | Association de kynurénine et de cellules présentatrices d'antigène (cpa) en tant qu'agent thérapeutique, et méthodes d'utilisation de cette dernière dans la modulation immunitaire | |
EP3212280A4 (fr) | Procédé d'adaptation aux acouphènes chez des patients à ic et à itc | |
HRP20182167T1 (hr) | Derivati benzilhidroksida, njihova priprava i njihova terapeutska uporaba | |
EP3384900A4 (fr) | Forme galénique stabilisé d'un conjugué d'éthydronate avec le citrabine et son utilisation |